FDA action counts
| Total FDA actions | 1 |
|---|---|
| Warning letters | 1 |
| Recalls | 0 |
| Approval records | 0 |
| Form 483 inspection citations | 0 |
| Most recent action | September 21, 2026 |
Enforcement history
On 2026-09-21, Argus HQ recorded an FDA Warning Letter for Babikian Healthcare Products CJSC, rated "high" severity in Argus HQ's classification: Babikian Healthcare Products CJSC — CGMP/Finished Pharmaceuticals/Adulterated (2026-09-21). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.
Risk pattern analysis
Argus HQ analysis — not an FDA finding
This section is Argus HQ analysis, not an FDA finding. Babikian Healthcare Products CJSC has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.
Frequently asked questions
- How many FDA actions does Argus HQ track for Babikian Healthcare Products CJSC?
- 1 total: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
- What is the most recent FDA action on file for Babikian Healthcare Products CJSC?
- September 21, 2026. Argus HQ ingests new FDA enforcement records daily.
- Has Babikian Healthcare Products CJSC received FDA warning letters?
- Yes, 1 warning letter on file. See the full history below for each one.
- Is this FDA enforcement data for Babikian Healthcare Products CJSC official?
- Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
Every FDA action tied to this company, the week it happens.
Free weekly briefing. Real-time alerts on paid plans.
Related enforcement actions
Compare with
- Babikian Healthcare Products CJSC vs Philips North America
- Babikian Healthcare Products CJSC vs Medline Industries, LP
- Babikian Healthcare Products CJSC vs Boston Scientific Corporation
- Babikian Healthcare Products CJSC vs Baxter Healthcare Corporation
- Babikian Healthcare Products CJSC vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Verified from FDA.gov · Last updated: Sep 21, 2026Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Babikian Healthcare Products CJSC — FDA Enforcement History. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/babikian-healthcare-products-cjsc
"Babikian Healthcare Products CJSC — FDA Enforcement History." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/babikian-healthcare-products-cjsc.
Argus HQ Research. "Babikian Healthcare Products CJSC — FDA Enforcement History." Digital Empire Holdings LLC. Accessed October 13, 2026. https://argushq.ai/company/babikian-healthcare-products-cjsc.
@misc{argushq_argushq_ai_company_babikian_healthcare_products_cjsc_2026,
title = {Babikian Healthcare Products CJSC — FDA Enforcement History},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire Holdings LLC},
url = {https://argushq.ai/company/babikian-healthcare-products-cjsc},
note = {Accessed: October 13, 2026}
}Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗